Table 4 All-cause mortality and CVD mortality in dyslipidemia participants

q1 [-4.63,0.35]

ref

ref

ref

ref

ref

ref

431/3248

q2 (0.35,1.82]

1.52(1.30,1.76)

< 0.01

1.48(1.26,1.73)

< 0.01

1.39(1.20,1.62)

< 0.01

572/3243

q3 (1.82,2.99]

1.64(1.35,1.99)

< 0.01

1.54(1.27,1.88)

< 0.01

1.37(1.13,1.65)

< 0.01

607/3245

q4 [2.99,5.47]

1.93(1.57,2.37)

< 0.01

1.81(1.49,2.20)

< 0.01

1.50(1.24,1.82)

< 0.01

593/3345

P for trend

< 0.01

< 0.01

< 0.01

CVD mortality in dyslipidemia across quartiles of DII

558/12,981

q1 [-4.63,0.35]

ref

ref

ref

ref

ref

ref

113/3248

q2 (0.35,1.82]

1.60(1.08,2.35)

0.02

1.53(1.05,2.23)

0.03

1.46(1.00,2.13)

0.05

147/3243

q3 (1.82,2.99]

1.72(1.19,2.48)

< 0.01

1.57(1.10,2.25)

0.01

1.38(0.94,2.01)

0.10

161/3245

q4 [2.99,5.47]

2.72(1.83,4.05)

< 0.01

2.52(1.71,3.73)

< 0.01

2.07(1.38,3.09)

< 0.01

167/3345

P_{for trend}

< 0.01

< 0.01

< 0.01